Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Cash from Operations (2016 - 2026)

Tandem Diabetes Care filings provide 13 years of Cash from Operations readings, the most recent being 9789000.0 for Q4 2025.

  • On a quarterly basis, Cash from Operations fell 8.66% to 9789000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 9721000.0, a 140.13% decrease, with the full-year FY2025 number at 9721000.0, down 140.13% from a year prior.
  • Cash from Operations hit 9789000.0 in Q4 2025 for Tandem Diabetes Care, up from 8264000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 34144000.0 in Q3 2021 to a low of 18326000.0 in Q1 2023.
  • Median Cash from Operations over the past 5 years was 7582500.0 (2022), compared with a mean of 7225850.0.
  • Biggest five-year swings in Cash from Operations: crashed 232.8% in 2023 and later skyrocketed 48589.09% in 2024.
  • Tandem Diabetes Care's Cash from Operations stood at 19635000.0 in 2021, then plummeted by 70.36% to 5820000.0 in 2022, then tumbled by 223.99% to 7216000.0 in 2023, then skyrocketed by 248.52% to 10717000.0 in 2024, then fell by 8.66% to 9789000.0 in 2025.
  • The last three reported values for Cash from Operations were 9789000.0 (Q4 2025), 8264000.0 (Q3 2025), and 9496000.0 (Q2 2025) per Business Quant data.